Dendritic cell-based active specific immunotherapy for malignant glioma. - Wikidata - awgldk - TriplyDB

Dendritic cell-based active specific immunotherapy for malignant glioma.

Dendritic cell-based active specific immunotherapy for malignant glioma.

http://www.wikidata.org/entity/Q36764903

about

In-vitro activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells.Immunotherapy of malignant brain tumors.Generation and immunologic functions of Th17 cells in malignant gliomas.Scutellaria extract and wogonin inhibit tumor-mediated induction of T(reg) cells via inhibition of TGF-β1 activity.Achieving graft-versus-tumor effect in brain tumor patients: from autologous progenitor cell transplant to active immunotherapy.Role of IL-17 in Glioma Progression Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice.Delayed growth of glioma by a polysaccharide from Aster tataricus involve upregulation of Bax/Bcl-2 ratio, activation of caspase-3/8/9, and downregulation of the Akt.Delayed growth of glioma by Scutellaria flavonoids involve inhibition of Akt, GSK-3 and NF-κB signaling.

P2860

Q34382848-5B380FED-8119-4A99-8D54-38D0CEDF7888 Q36162929-B6815B83-5393-402A-9F75-0C33539F5F44 Q37463208-4A196F1C-A998-4D49-8990-E28C64DD7603 Q37520219-043B4002-7E81-4B38-BCD7-B4E12FE05AE6 Q38063583-D63ABFF0-CAE6-4624-9FC5-F199884FA465 Q38270824-40710A6E-B150-471B-A31B-FD258DA1379B Q38909897-7E690C60-C604-48BC-9685-1A91F78F614C Q39089512-D2F67356-2B02-4598-95F4-C30C9761876D Q41889454-A82DCEAC-58B3-4ECC-B45A-9FA8CA402A5B

P2860

Dendritic cell-based active specific immunotherapy for malignant glioma.

http://www.wikidata.org/entity/Q36764903

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Dendritic cell-based active specific immunotherapy for malignant glioma.

@ast

Dendritic cell-based active specific immunotherapy for malignant glioma.

@en

type

label

Dendritic cell-based active specific immunotherapy for malignant glioma.

@ast

Dendritic cell-based active specific immunotherapy for malignant glioma.

@en

prefLabel

Dendritic cell-based active specific immunotherapy for malignant glioma.

@ast

Dendritic cell-based active specific immunotherapy for malignant glioma.

@en

P1433

Q36764903-49089449-54A0-423D-8779-C54DE9755062

P1476

Q36764903-285AE651-A576-4406-B42D-1032C2E14F16

P2093

Q36764903-2C8BC098-8C28-4C25-858C-1F1EC20577E6

Q36764903-A15A5F39-41D3-4391-BD4F-EB7706BC7704

Q36764903-D112B53B-6A37-44AA-A86A-B7776A2A686F

Q36764903-E0242344-D90C-4892-AA1E-4DFDE40EA543

P2860

Q36764903-05116EB9-CB80-4AE9-AFD4-6961B724ECCB

Q36764903-0ED04D83-267B-4646-826E-9FFDDDA5A3DB

Q36764903-1053B333-9B37-4037-8135-6A3299C3705C

Q36764903-24310863-A1F8-4990-B5F1-53EF130C8183

Q36764903-2464414E-C72C-4B49-A8F8-132A31E5BF65

Q36764903-271056A3-2ED5-4A3B-86BA-771BFDED781E

Q36764903-327A079C-B5AB-4853-9509-049938A91182

Q36764903-3D26A929-419E-4B8F-AEFB-B7DA89A68D67

Q36764903-40171DC3-EF18-4CF9-8A14-FB24C5D621BC

Q36764903-402DC1D9-FFF5-440F-89B5-77EF5E006636

P304

Q36764903-B1D8FDF5-9241-4956-B91A-C7561B563DD8

P31

Q36764903-35E8E869-72AD-4C33-9481-E6C5173865C6

P356

Q36764903-EA6A4968-9E9B-4C4E-A9E8-C38482C62FC8

P407

Q36764903-9CA55F5D-56C4-4183-90E2-7A90DD5C6065

P433

Q36764903-DC831D42-6936-406B-A2EC-6CB25614E945

P478

Q36764903-FC688239-078A-4CDC-BD1C-992668819FE6

P577

Q36764903-E4EAB855-4A42-4C35-AE49-B1A3B4A56D07

P698

Q36764903-6FAEAE90-9858-435C-A63D-96F5F3F31CCF

P921

Q36764903-1EFB83F4-5767-47A7-A038-AD022992F4BD

P356

14712598.7.4.439

P1433

Expert Opinion on Biological Therapy

P1476

Dendritic cell-based active specific immunotherapy for malignant glioma.

@en

P2093

Andrew E Sloan

http://www.w3.org/2001/XMLSchema#string

Prahlad Parajuli

http://www.w3.org/2001/XMLSchema#string

Sandeep Mittal

http://www.w3.org/2001/XMLSchema#string

Saroj Mathupala

http://www.w3.org/2001/XMLSchema#string

P2860

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

Regulatory T cells in cancer.

Therapeutic options for recurrent high-grade glioma in adult patients: recent advances.

Modulation of the immune response by transforming growth factor beta.

An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme.

Cellular immunotherapy with dendritic cells in cancer: current status.

Dendritic cell-based immunotherapy of malignant gliomas.

Dendritic cells in vaccination therapies of human malignant disease.

Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis.

Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation

P304

439-448

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.7.4.439

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2007-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17373896

http://www.w3.org/2001/XMLSchema#string

P921